Top Ten Equity Holdings and Exposures

RNS Number : 1536W
Polar Cap Gbl Healthcare Growth&IT
06 February 2017
 

6th February 2017

 

Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st January 2017 and full Portfolio listing as at 30th December 2016 available from company's website

 

Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 31st January 2017 the top ten equity holdings and the sector and geographic breakdown were as follows:   

 

Top 10 Holdings         

%

Merck & Co

7.6%

Pfizer

7.4%

Johnson & Johnson

6.0%

GlaxoSmithKline

5.0%

Sanofi

4.9%

Roche

4.7%

Novartis

4.6%

Astellas Pharma

3.8%

Merck KGaA

3.7%

Bristol Myers Squibb

3.1%

Total

50.8%

 

 

 

Sector Exposure

%

Pharmaceuticals

62.4%

Healthcare Equipment

9.4%

Biotechnology

8.4%

Healthcare REITs

5.7%

Healthcare Services

4.3%

Healthcare Facilities

3.8%

Managed Healthcare

3.2%

Healthcare Supplies

0.8%

Life & Health Insurance

0.6%

Life Sciences Tools & Services

0.5%

Healthcare Distributors

0.2%

Cash

0.8%

Total

100.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Geographic Exposure

%

United States

50.3%

United Kingdom

10.7%

Switzerland

10.0%

Japan

5.9%

France

4.9%

Germany

4.2%

Australia

2.9%

Ireland

2.8%

Israel

2.8%

Canada

2.1%

Italy

0.8%

India

0.8%

Denmark

0.6%

Norway

0.5%

Cash

0.8%

Total

100%

 

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com 

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUKMGGZKVKGNZM
UK 100

Latest directors dealings